These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Burning Mouth Syndrome: An Overview and Future Perspectives. Adamo D; Spagnuolo G Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36613002 [TBL] [Abstract][Full Text] [Related]
24. [Etiopathogenic, clinical-diagnostic and therapeutic aspects of the burning mouth syndrome. Research and treatment protocols in a patient group]. Lauritano D; Spadari F; Formaglio F; Zambellini Artini M; Salvato A Minerva Stomatol; 1998 Jun; 47(6):239-51. PubMed ID: 9738358 [TBL] [Abstract][Full Text] [Related]
25. One-year follow-up for the therapeutic efficacy of pregabalin in patients with leg symptoms caused by lumbar spinal stenosis. Takahashi N; Arai I; Kayama S; Ichiji K; Fukuda H; Konno S J Orthop Sci; 2014 Nov; 19(6):893-9. PubMed ID: 25338293 [TBL] [Abstract][Full Text] [Related]
26. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings. Navarro A; Saldaña MT; Pérez C; Torrades S; Rejas J Pain Med; 2010 May; 11(5):719-31. PubMed ID: 20345618 [TBL] [Abstract][Full Text] [Related]
27. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial. van Seventer R; Bach FW; Toth CC; Serpell M; Temple J; Murphy TK; Nimour M Eur J Neurol; 2010 Aug; 17(8):1082-9. PubMed ID: 20236172 [TBL] [Abstract][Full Text] [Related]
32. An overview of burning mouth syndrome for the dermatologist. Lewis AK; Prime SS; Cohen SN Clin Exp Dermatol; 2016 Mar; 41(2):119-23. PubMed ID: 26871710 [TBL] [Abstract][Full Text] [Related]
33. Is burning mouth syndrome a neuropathic pain condition? Jääskeläinen SK Pain; 2018 Mar; 159(3):610-613. PubMed ID: 29257770 [TBL] [Abstract][Full Text] [Related]
34. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343 [TBL] [Abstract][Full Text] [Related]
36. Peripheral nervous system involvement in primary burning mouth syndrome--results of a pilot study. Puhakka A; Forssell H; Soinila S; Virtanen A; Röyttä M; Laine M; Tenovuo O; Teerijoki-Oksa T; Jääskeläinen SK Oral Dis; 2016 May; 22(4):338-44. PubMed ID: 26847146 [TBL] [Abstract][Full Text] [Related]
38. Abnormalities of the blink reflex in burning mouth syndrome. Jääskeläinen SK; Forssell H; Tenovuo O Pain; 1997 Dec; 73(3):455-460. PubMed ID: 9469537 [TBL] [Abstract][Full Text] [Related]
39. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354 [TBL] [Abstract][Full Text] [Related]
40. Steroid dysregulation and stomatodynia (burning mouth syndrome). Woda A; Dao T; Gremeau-Richard C J Orofac Pain; 2009; 23(3):202-10. PubMed ID: 19639097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]